Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 23883968)

1.

New insights into pre-BCR and BCR signalling with relevance to B cell malignancies.

Rickert RC.

Nat Rev Immunol. 2013 Aug;13(8):578-91. doi: 10.1038/nri3487. Review. Erratum in: Nat Rev Immunol. 2013 Sep;13(9):701.

PMID:
23883968
2.

ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.

Gobessi S, Laurenti L, Longo PG, Sica S, Leone G, Efremov DG.

Blood. 2007 Mar 1;109(5):2032-9. Epub 2006 Oct 12.

3.

B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies.

Puri KD, Di Paolo JA, Gold MR.

Int Rev Immunol. 2013 Aug;32(4):397-427. doi: 10.3109/08830185.2013.818140. Review.

PMID:
23886342
4.

Bruton tyrosine kinase (BTK) and its role in B-cell malignancy.

Buggy JJ, Elias L.

Int Rev Immunol. 2012 Apr;31(2):119-32. doi: 10.3109/08830185.2012.664797. Review. Erratum in: Int Rev Immunol. 2012 Oct;31(5):428.

PMID:
22449073
5.

Atypical B cell receptor signaling: straddling immune diseases and cancer.

Faris M.

Int Rev Immunol. 2013 Aug;32(4):355-7. doi: 10.3109/08830185.2013.817248. Epub 2013 Jul 12.

PMID:
23848467
6.

BCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies.

Robak T, Robak P.

Int Rev Immunol. 2013 Aug;32(4):358-76. doi: 10.3109/08830185.2013.786711. Epub 2013 Apr 25. Review.

PMID:
23617253
7.

Autoinhibition and adapter function of Syk.

Kulathu Y, Grothe G, Reth M.

Immunol Rev. 2009 Nov;232(1):286-99. doi: 10.1111/j.1600-065X.2009.00837.x. Review.

PMID:
19909371
8.

Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt.

Craxton A, Jiang A, Kurosaki T, Clark EA.

J Biol Chem. 1999 Oct 22;274(43):30644-50.

9.

Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals.

McCaig AM, Cosimo E, Leach MT, Michie AM.

Br J Haematol. 2011 Apr;153(2):199-211. doi: 10.1111/j.1365-2141.2010.08507.x. Epub 2011 Feb 24.

PMID:
21352196
10.

Targeting the B cell receptor pathway in chronic lymphocytic leukemia.

Davids MS, Brown JR.

Leuk Lymphoma. 2012 Dec;53(12):2362-70. doi: 10.3109/10428194.2012.695781. Review.

PMID:
22616724
11.

The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach.

Sivina M, Kreitman RJ, Arons E, Ravandi F, Burger JA.

Br J Haematol. 2014 Jul;166(2):177-88. doi: 10.1111/bjh.12867. Epub 2014 Apr 2.

PMID:
24697238
12.

B cell receptor signaling in chronic lymphocytic leukemia.

Burger JA, Chiorazzi N.

Trends Immunol. 2013 Dec;34(12):592-601. doi: 10.1016/j.it.2013.07.002. Epub 2013 Aug 5. Review.

13.

Cross-linking of B cell antigen receptor-related structure of pre-B cell lines induces tyrosine phosphorylation of p85 and p110 subunits and activation of phosphatidylinositol 3-kinase.

Kuwahara K, Kawai T, Mitsuyoshi S, Matsuo Y, Kikuchi H, Imajoh-Ohmi S, Hashimoto E, Inui S, Cooper MD, Sakaguchi N.

Int Immunol. 1996 Aug;8(8):1273-85.

14.

Syk mediates BCR- and CD40-signaling integration during B cell activation.

Ying H, Li Z, Yang L, Zhang J.

Immunobiology. 2011 May;216(5):566-70. doi: 10.1016/j.imbio.2010.09.016. Epub 2010 Oct 7.

15.

The kinase Syk as an adaptor controlling sustained calcium signalling and B-cell development.

Kulathu Y, Hobeika E, Turchinovich G, Reth M.

EMBO J. 2008 May 7;27(9):1333-44. doi: 10.1038/emboj.2008.62. Epub 2008 Mar 27.

16.

Cutting edge: constitutive B cell receptor signaling is critical for basal growth of B lymphoma.

Gururajan M, Jennings CD, Bondada S.

J Immunol. 2006 May 15;176(10):5715-9. Erratum in: J Immunol. 2006 Jun 15;176(12):7789.

17.

Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells.

Feldhahn N, Klein F, Mooster JL, Hadweh P, Sprangers M, Wartenberg M, Bekhite MM, Hofmann WK, Herzog S, Jumaa H, Rowley JD, Müschen M.

J Exp Med. 2005 Jun 6;201(11):1837-52.

18.

The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.

Klein F, Feldhahn N, Harder L, Wang H, Wartenberg M, Hofmann WK, Wernet P, Siebert R, Müschen M.

J Exp Med. 2004 Mar 1;199(5):673-85.

19.

Syk tyrosine kinase required for mouse viability and B-cell development.

Cheng AM, Rowley B, Pao W, Hayday A, Bolen JB, Pawson T.

Nature. 1995 Nov 16;378(6554):303-6.

PMID:
7477353
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk